# Nephrology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Madam C. J. Walker (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET019-SYN-TD
- Date: 1917-02-09
- Fictional facility: St. Posthumous Health Center
- Fictional author: Harriet Okonjo-Bell, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- To: Desmond Achterberg, MD, Nephrology
- Urgency: Within two weeks, on the day of her two-week visit, so that she makes one trip

## Referral question

Albumin in the urine (286 mg/g) and an eGFR of 54 by the race-free CKD-EPI 1912 equation in a 49-year-old woman with high blood pressure readings awaiting ambulatory confirmation, left ventricular hypertrophy on ECG and protein on a dipstick a year ago. Please advise on the cause, any further tests, kidney-protective treatment and her blood pressure target, APOL1 testing, and a monitoring plan that fits a schedule of travel most weeks. **S**

## Questions for the consultant

1. Is this hypertensive kidney disease, or does she need tests for another cause, or a kidney biopsy?
2. Which medicines do you advise for her blood pressure and kidneys, and what is her blood pressure target?
3. Should she start an SGLT2 inhibitor without diabetes?
4. Should she be offered APOL1 genetic testing, and how would the result be used?
5. How should we monitor potassium, creatinine and albumin, given that she travels most weeks?
6. What is her risk of kidney failure, and when should she see you again?

## Pertinent history

She founded and runs a hair-care company with a national network of sales agents and travels most weeks to train and speak. A workplace screening found high blood pressure; she has had morning headaches for some months. Her office has requested last year's executive physical results, which she recalls showed protein in the urine. No diabetes, no NSAID use, no kidney stones, no known family kidney disease; both parents died when she was a child. Today: blood pressure 166/102 (average of two readings), pulse 82, weight 79.0 kg, BMI 29.7. Fundi: mild arteriolar narrowing without hemorrhages. Results today: sodium 140, potassium 4.4, bicarbonate 25 mmol/L; creatinine 1.22 mg/dL, eGFR 54 (CKD-EPI 1912, race-free); glucose 94 mg/dL; A1c 5.4%; urine albumin-to-creatinine ratio 286 mg/g; urinalysis 1+ protein, no blood, bland sediment; total cholesterol 250, LDL 174, HDL 46, triglycerides 150 mg/dL; hemoglobin 12.4 g/dL; TSH 1.9. ECG: sinus rhythm, left ventricular hypertrophy by voltage criteria. Planned before your visit: 24-hour ambulatory monitoring and home readings, a repeat urine albumin and creatinine, calcium, phosphate, parathyroid hormone and 25-hydroxyvitamin D, and a kidney ultrasound on the morning of your visit. No medicines started yet. **S**

- Madam C. J. Walker was born Sarah Breedlove on December 23, 1867, in Delta, Louisiana, the daughter of Owen and Minerva Anderson Breedlove. Both parents had been enslaved on a Madison Parish plantation, and she was their first child born into freedom. **D**
- Both her parents had died by the time she was seven, and she went to live with an older sister and moved across the river to Vicksburg, Mississippi. She married Moses McWilliams at fourteen, had her only child, Lelia (later A'Lelia), and was widowed at twenty. She then moved to St. Louis, where she worked as a laundress and cook, sometimes for as little as a dollar a day. **D**
- While working as a laundress she began to lose her hair, a problem many Black women of her time shared. Her biographers attribute it to scalp disease such as dandruff, poor diet, a hard life and harsh washing products, in an era when most homes lacked indoor plumbing. In 1904 she began using and selling another Black woman's hair grower as a sales agent, then developed her own sulfur-containing ointments and shampoos to treat scalp disease. **D**
- In Denver she married Charles Joseph Walker, a newspaper advertising salesman (in January 1906, or 1905 in one account), and began calling herself Madam Walker, in part to avoid the familiar forms of address then used for Black women. She launched her own hair-care line there, set up headquarters and a training school for her agents in Pittsburgh in 1908, and moved the company to Indianapolis in 1910. She trained thousands of sales agents, "hair culturists," who earned a share of the profits. She kept the name after the marriage ended. **D**
- As her wealth grew she became a philanthropist and activist: she gave to the YWCA and paid tuition for students at Tuskegee Institute, and in 1915 she sued over discrimination at an Indianapolis theater. **D**
- The physical demands she placed on herself undermined her health, and she suffered from high blood pressure. She went for a rest cure at Hot Springs, Arkansas, in 1916, but otherwise did not slow her pace. **D**

4 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: Sodium: 140 mmol/L; Potassium: 4.4 mmol/L; Bicarbonate (total CO2): 25 mmol/L; Creatinine: 1.22 mg/dL (high); Glucose: 94 mg/dL; eGFR (CKD-EPI 1912, race-free): 54 mL/min/1.73 m² (low); Urine albumin-to-creatinine ratio: 286 mg/g (high); Hemoglobin A1c: 5.4%; Total cholesterol: 250 mg/dL (high); LDL cholesterol: 174 mg/dL (high); HDL cholesterol: 46 mg/dL (low); Triglycerides: 150 mg/dL (high); Hemoglobin: 12.4 g/dL; TSH: 1.9 mIU/L; PHQ-9: 4. All results are synthetic.

BP 166/102 mmHg; pulse 82 bpm; respirations 16/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 79 kg; BMI 29.7 kg/m². All vital signs are synthetic.

## Current medications

- No current medications. **S**

## Plan so far

- Confirm the diagnosis outside the office: 24-hour ambulatory monitoring on a day at home, and a validated upper-arm home monitor with a correctly sized cuff that travels with her, two readings morning and evening for seven days, travel days included; recheck in two weeks. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, hyperlipidemia and depression monographs (2026) **S**
- Kidney evaluation: repeat urine albumin and creatinine at two weeks, compared with last year's results to establish chronicity; urinalysis; kidney ultrasound; calcium, phosphate, parathyroid hormone and 25-hydroxyvitamin D at baseline; every eGFR reported by the race-free CKD-EPI 1912 equation; no ibuprofen or naproxen. Guideline: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race (2021); A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease (2021); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, hyperlipidemia and depression monographs (2026) **S**
- Heart and vascular risk: ECG at intake and an echocardiogram for the left ventricular hypertrophy it shows; a fundus examination; TSH and A1c at diagnosis; lipid panel and 10-year ASCVD risk by the Pooled Cohort Equations. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, hyperlipidemia and depression monographs (2026) **S**
- Food: sodium under 2 g a day built on what she eats, not a new diet: a salt-free seasoning blend for the dishes she cooks on Sundays, smoked turkey in small amounts in place of salt pork, ordering strategies for banquets and restaurants, water instead of a third coffee on travel days; video sessions with a registered dietitian between trips; no potassium-based salt substitutes until her kidney tests and any new medicines are settled. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024) **S**
- Work and rest on her terms: she sets her schedule; the risks of uncontrolled blood pressure and kidney disease are stated plainly and any medicines are chosen to do the work, timed to her home clock across time zones, with a written sick-day card for her bag; a protected sleep window on travel nights and walking during layovers; video visits between trips and laboratory checks on her days at home. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024) **S**
- Mood and stress: PHQ-9 at intake and yearly. Guideline: CMID: Clinical Monitoring Intelligence Database, hypertension, chronic kidney disease, hyperlipidemia and depression monographs (2026); Depression and Suicide Risk in Adults: Screening (2023) **S**
- Vaccines: influenza today; pneumococcal, hepatitis B and Tdap needs reviewed at the preventive visit; influenza and COVID-19 each autumn. Guideline: Adult Immunization Schedule by Age (2026) **S**
